Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

World journal of gastroenterology - 21 Aug 2014

Fitzpatrick Emer, Dhawan Anil

Abstract excerpt

The development of non invasive biomarkers of disease has become a major focus of interest in nonalcoholic fatty liver disease (NAFLD). The large prevalence of the disease and the invasive nature of the investigation means that screening with liver biopsy is impractical. In addition to screening, the differentiation of those with simple steatosis vs steatohepatitis and fibrosis is clinically important as the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Diagnostic Imaging
Share to Elasticity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Elasticity Imaging Techniques

Share to Liver Cirrhosis

Share to Non-alcoholic Fatty Liver Disease

Share to Predictive Value of Tests

Share to Proteomics

Source

Open in PubMed Open full text

Identifiers

PMID: 25152587
DOI: 10.3748/wjg.v20.i31.10851
PMCID: PMC4138464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.PMID 25152587Read ↗

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.Semantic proximity Read ↗

Liver Fibrosis Conventional and Molecular Imaging Diagnosis UpdateSemantic proximity Read ↗

FibroMAX™: towards a new universal biomarker of liver disease?Semantic proximity Read ↗

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read ↗

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.Semantic proximity Read ↗

Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.Semantic proximity Read ↗

Thermoacoustic ultrasound assessment of liver steatosis - a novel approach for MASLD diagnosisSemantic proximity Read ↗

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read ↗

Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Semantic proximity Read ↗

Genomics and proteomics in liver fibrosis and cirrhosisSemantic proximity Read ↗

Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population.Semantic proximity Read ↗

Noninvasive characterization of graft steatosis after liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.